From its initial use in the treatment of type 2 diabetes to its expansion to 12 indications such as obesity, cardiovascular disease, chronic kidney disease, and metabolic dysfunction related fatty liver disease (MASLD), the annual sales of GLP-1 drugs exceeded 100 billion dollars, and its research and development funding reached a historical peak of 21.72 million dollars in 2025
Pietrzykowska, MD, FACP, is a Board Certified Obesity Medicine Specialist, Physician Nutrition Specialist and Health Coach
Talking To HR Or Benefits Managers About Coverage If you discover your company's health plan doesn't offer the insurance coverage you need, your next step could be to talk to your HR department or benefits manager
During last Monday's episode of ABC's "The Bachelor," a commercial touted "the revolutionary weight-loss medication everyone is talking about." "With Ro, get the online coaching and care you need to lose 15% of your body weight with one weekly shot," a voiceover for the hot digital-health startup boomed
GREAT VALUE - you get 180 capsules in each jar.
